COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 438: Articles 4371-4380  | Next

Preparing correctional settings for the next pandemic: a modelling study of COVID-19 outbreaks in two high-income countries
Kwon, J. A., Bretana, N. A., Kronfli, N., Dussault, C., Grant, L., Galouzis, J., Hoey, W., Blogg, J., Lloyd, A. R., Gray, R. T.
10.1101/2023.05.08.23289690 — Posted: 2023-05-10
Tracking the prevalence and emergence of SARS CoV2 variants of concern using a regional genomic surveillance program
Jung, A., Droit, L., Febles, B., Fronick, C., Cook, L., Handley, S. A., Parikh, B. A., Wang, D.
10.1101/2023.05.08.23289687 — Posted: 2023-05-10
Severity of SARS-CoV-2 Omicron XBB subvariants in Singapore
Pung, R., Kong, X. P., Lin, C., Chae, S.-R., Chen, M. I.-C., Lee, V., Ho, Z. J. M.
10.1101/2023.05.04.23289510 — Posted: 2023-05-10
Surveillance strategies for the detection of new SARS-CoV-2 variants across epidemiological contexts
Oliveira Roster, K. I., Kissler, S. M., Omoregie, E., Wang, J. C., Amin, H. S., Di Lonardo, S., Hughes, S., Grad, Y.
10.1101/2023.05.09.23289744 — Posted: 2023-05-10
Persistent humoral immunity in children and adolescents throughout the COVID-19 pandemic (June 2020 to July 2022): a prospective school-based cohort study (Ciao Corona) in Switzerland
Raineri, A., Radtke, T., Rueegg, S., Haile, S. R., Menges, D., Ballouz, T., Ulyte, A., Fehr, J., Cornejo, D. L., Pantaleo, G., Pellaton, C., Fenwick, C., Puhan, M. A., Kriemler, S.
10.1101/2023.05.08.23289517 — Posted: 2023-05-10
Healthcare resource utilisation and costs of hospitalisation and primary care among adults with COVID-19 in England: a population-based cohort study
Yang, J., Andersen, K. M., Rai, K. K., Tritton, T., Mugwagwa, T., Reimbaeva, M., Tsang, C., McGrath, L., Payne, P., Backhouse, B. E., Mendes, D., Butfield, R., Naicker, K., Araghi, M., Wood, R., Nguyen, J.
10.1101/2023.05.10.23289557 — Posted: 2023-05-10
PandoGen: Generating complete instances of future SARS-CoV2 sequences using Deep Learning
Ramachandran, A., Lumetta, S. S., Chen, D.
10.1101/2023.05.10.540124 — Posted: 2023-05-10
Single-cell transcriptome landscape of circulating CD4+ T cell populations in human autoimmune diseases
Yasumizu, Y., Takeuchi, D., Morimoto, R., Takeshima, Y., Okuno, T., Kinoshita, M., Morita, T., Kato, Y., Wang, M., Motooka, D., Okuzaki, D., Nakamura, Y., Mikami, N., Arai, M., Zhang, X., Kumanogoh, A., Mochizuki, H., Ohkura, N., Sakaguchi, S.
10.1101/2023.05.09.540089 — Posted: 2023-05-10
ENDO-LYSOSOME-TARGETED NANOPARTICLE DELIVERY OF ANTIVIRAL THERAPY FOR CORONAVIRUS INFECTIONS
Petcherski, A., Tingley, B., Martin, A., Adams, S., Brownstein, A., Steinberg, R., Shabane, B., Garcia, G., Veliova, M., Arumugaswami, V., Colby, A., Shirihai, O., Grinstaff, M.
10.1101/2023.05.08.539898 — Posted: 2023-05-09
Dissecting the impact of somatic hypermutation on SARS-CoV-2 neutralization and viral escape
Korenkov, M., Zehner, M., Cohen-Dvashi, H., Borenstein-Katz, A., Kottege, L., Janicki, H., Vanshylla, K., Weber, T., Gruell, H., Koch, M., Diskin, R., Kreer, C., Klein, F.
10.1101/2023.05.09.539943 — Posted: 2023-05-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).